3,3′-Diindolylmethane attenuates experimental arthritis and osteoclastogenesis

Biochemical Pharmacology

Volumn 79, Issue 5, 2010, Pages 715-721

  Dong, Lei ^a   Xia, Suhua ^a   Gao, Fengbo ^a   Zhang, Dachuan ^a   Chen, Jiangning ^a   Zhang, Junfeng ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

3,3 Diindolylmethane; Arthritis; Osteoclastogenesis; RANKL

Indexed keywords

3,3' DIINDOLYLMETHANE; ADJUVANT; CYTOKINE; OSTEOCLAST DIFFERENTIATION FACTOR; 3,3'-DIINDOLYLMETHANE; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; BONE DEVELOPMENT; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FIBROBLAST; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PAW EDEMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; EDEMA; GROWTH, DEVELOPMENT AND AGING; HINDLIMB; MALE; METABOLISM; OSTEOCLAST; PATHOLOGY; SKULL; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ANTICARCINOGENIC AGENTS; ARTHRITIS, EXPERIMENTAL; BONE RESORPTION; CELLS, CULTURED; CYTOKINES; EDEMA; FEMALE; FIBROBLASTS; HINDLIMB; INDOLES; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; OSTEOCLASTS; RANK LIGAND; RATS; RATS, SPRAGUE-DAWLEY; SKULL;

EID: 71849091508     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.10.010     Document Type: Article

References (30)

1. Rahman K.M., Banerjee S., Ali S., Ahmad A., Wang Z., Kong D., et al. 3,3′-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation. Cancer Res 69 (2009) 4468-4475
2. McGuire K.P., Ngoubilly N., Neavyn M., and Lanza-Jacoby S. 3,3′-Diindolylmethane and paclitaxel act synergistically to promote apoptosis in HER2/Neu human breast cancer cells. J Surg Res 132 (2006) 208-213
3. Okino S.T., Pookot D., Basak S., and Dahiya R. Toxic and chemopreventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention. Cancer Prev Res (Phila Pa) 2 (2009) 251-256
4. Cho H.J., Seon M.R., Lee Y.M., Kim J., Kim J.K., Kim S.G., et al. 3,3′-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophages. J Nutr 138 (2008) 17-23
5. Kim Y.H., Kwon H.S., Kim D.H., Shin E.K., Kang Y.H., Yoon Park J.H., et al. 3,3′-diindolylmethane attenuates colonic inflammation and tumorigenesis in mice. Inflamm Bowel Dis 15 (2009) 1164-1173
6. Jellinck P.H., Forkert P.G., Riddick D.S., Okey A.B., Michnovicz J.J., and Bradlow H.L. Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45 (1993) 1129-1136
7. Chen I., Safe S., and Bjeldanes L. Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochem Pharmacol 51 (1996) 1069-1076
8. Chen I., McDougal A., Wang F., and Safe S. Aryl hydrocarbon receptor-mediated antiestrogenic and anti tumorigenic activity of diindolylmethane. Carcinogenesis 19 (1998) 1631-1639
9. Riddick D.S., Huang Y., Harper P.A., and Okey A.B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of CYP1A1. J Biol Chem 269 (1994) 12118-12128
10. Naruse M., Otsuka E., Naruse M., Ishihara Y., Miyagawa-Tomita S., and Hagiwara H. Inhibition of osteoclast formation by 3-methylcholanthrene, a ligand for arylhydrocarbon receptor: suppression of osteoclast differentiation factor in osteogenic cells. Biochem Pharmacol 67 (2004) 119-127
11. Yavropoulou M.P., and Yovos J.G. Osteoclastogenesis-current knowledge and future perspectives. J Musculoskelet Neuronal Interact 8 (2008) 204-216
12. Sato K., and Takayanagi H. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 18 (2006) 419-426
13. Wei S., and Siegal G.P. Mechanisms modulating inflammatory osteolysis: a review with insights into therapeutic targets. Pathol Res Pract 204 (2008) 695-706
14. Tsutsumi R., Xie C., Wei X., Zhang X., Flick L.M., Schwarz E.M., et al. PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis. 1. J Bone Miner Res 24 (2009) 1753-1762
15. Pearson C.M., Waksman B.H., and Sharp J.T. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease. J Exp Med 113 (1961) 485-510
16. Taurog J.D., Kerwar S.S., McReynolds R.A., Sandberg G.P., Leary S.L., and Mahowald M.L. Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J Exp Med 162 (1985) 962-978
17. Ukai T., Hara Y., and Kato I. Effects of T cell adoptive transfer into nude mice on alveolar bone resorption induced by endotoxin. J Periodontal Res 31 (1996) 414-422
18. Chiang C.Y., Kyritsis G., Graves D.T., and Amar S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67 (1999) 4231-4236
19. Peacock D.J., Banquerigo M.L., and Brahn E. Angiogenesis inhibition suppresses collagen arthritis. J Exp Med 175 (1992) 1135-1138
20. Burbach K.M., Poland A., and Bradfield C.A. Cloning of the Ah receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc Natl Acad Sci USA 89 (1992) 8185-8189
21. Lyte M., and Bick P.H. Modulation of interleukin-1 production by macrophages following benzo(a)pyrene exposure. Int J Immunopharmacol 8 (1986) 377-381
22. Vandebriel R.J., Meredith C., Scott M.P., Roholl P.J., and Van Loveren H. Effects of in vivo exposure to bis(tri-n-butyltin)oxide, hexachlorobenzene, and benzo(a)pyrene on cytokine (receptor) mRNA levels in cultured rat splenocytes and on IL-2 receptor protein levels. Toxicol Appl Pharmacol 148 (1998) 126-136
23. Pei X.H., Nakanishi Y., Inoue H., Takayama K., Bai F., and Hara N. Polycyclic aromatic hydrocarbons induce IL-8 expression through nuclear factor kappaB activation in A549 cell line. Cytokine 19 (2002) 236-241
24. Lecureur V., Ferrec E.L., N'diaye M., Vee M.L., Gardyn C., Gilot D., et al. ERK-dependent induction of TNFalpha expression by the environmental contaminant benzo(a)pyrene in primary human macrophages. FEBS Lett 579 (2005) 1904-1910
25. Kobayashi S., Okamoto H., Iwamoto T., Toyama Y., Tomatsu T., Yamanaka H., et al. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 47 (2008) 1317-1322
26. Li P., Schwarz E.M., O'Keefe R.J., Ma L., Looney R.J., Ritchlin C.T., et al. Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum 50 (2004) 265-276
27. Ilvesaro J., Pohjanvirta R., Tuomisto J., Viluksela M., and Tuukkanen J. Bone resorption by aryl hydrocarbon receptor-expressing osteoclasts is not disturbed by TCDD in short-term cultures. Life Sci 77 (2005) 1351-1366
28. Riby J.E., Xue L., Chatterji U., Bjeldanes E.L., Firestone G.L., and Bjeldanes L.F. Activation and potentiation of interferon-gamma signaling by 3,3′-diindolylmethane in MCF-7 breast cancer cells. Mol Pharmacol 69 (2006) 430-439
29. Xue L., Pestka J.J., Li M., Firestone G.L., and Bjeldanes L.F. 3,3′-Diindolylmethane stimulates murine immune function in vitro and in vivo. J Nutr Biochem 19 (2008) 336-344
30. Strickley R.G. Solubilizing excipients in oral and injectable formulations [Review]. Pharm Res 21 (2004) 201-230